Switching patient support hub vendors is often necessary, but without the right partner and methodology, it can become a costly disruption to your program, patients and healthcare providers.
In this Drug Channels Institute article, Vice President of Business Development Brok Vandersteen explains how life sciences organizations can avoid the four most common transition pitfalls and execute a seamless hub program change with minimal disruption.
Drug Channels Institute is one of the industry’s leading publications offering expert insights on pharmaceutical economics and the drug distribution systems.